Visfatin and its role in obesity development

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F12%3A00061309" target="_blank" >RIV/00216224:14110/12:00061309 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1016/j.dsx.2012.08.011" target="_blank" >http://dx.doi.org/10.1016/j.dsx.2012.08.011</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.dsx.2012.08.011" target="_blank" >10.1016/j.dsx.2012.08.011</a>

Result language
angličtina
Original language name
Visfatin and its role in obesity development
Original language description
Visfatin, a product of PBEF gene, is an adipocytokine that harbours strong insulin-mimetic activity and it has been reported previously to associate with obesity. Recent reports also provide evidence that Visfatin has also important intracellular effectsas it is homologous with nicotinamide phosphoribosyltransferase (NAMPT). In this review, we summarize the main documented effects of Visfatin on metabolism in humans, with special emphasis put on the pathways associated with obesity.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FB - Endocrinology, diabetology, metabolism, nutrition
OECD FORD branch
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical
Diabetes & Metabolic Syndrome: Clinical Research & Reviews
ISSN
1871-4021
e-ISSN
—
Volume of the periodical
6
Issue of the periodical within the volume
2
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
5
Pages from-to
120-124
UT code for WoS article
—
EID of the result in the Scopus database
—

Similar results(10)